| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |